DHA (docosahexaenoic acid)
Intracellular DHA delivery promote homeostatic synaptic plasticity and neuroprotection in the hippocampus by increasing cAMP/PKA/CREB signaling
- BDNF-induced synaptogenesis is enhanced by intracellular DHA delivery to neural stem/progenitor cells (NSPCs)
- Increased CREB function (phosphorylation) may protect neurons from glutamate excitoxicity and neuroinflammation via phosphorylation of the NMDA receptor. 
- mBDNF transactivate the TrkB receptor and decrease the excitability of GABAergic interneurons. 
Neuroprotective properties of DHA
- DHA is neuroprotective and controlled by the P2X7 purinoreceptor. 
- DHA exert proneurogenic functions on activated microglia cells. 
DHA and vitamin D control of serotonin synthesis
DHEA (N-docosahexaenoyl ethanolamide)
- Ethanolamide metabolite of DHA.
- Derivative of anandamide.
- A synaptogenic endocannabinoid with antiglutamatergic and neuroprotective effects that induce synaptogenesis in vivo. 
Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1.
Mature BDNF, but not proBDNF, reduces excitability of fast-spiking interneurons in mouse dentate gyrus.
Purine receptors are required for DHA-mediated neuroprotection against oxygen and glucose deprivation in hippocampal slices.
Docosahexaenoic acid modulates inflammatory and antineurogenic functions of activated microglial cells.
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines.
Regulation of calcium signalling by docosahexaenoic acid in human T-cells. Implication of CRAC channels.
Effects of Docosahexaenoic Acid on Neurotransmission.